Progress of electrospun nanofibrous carriers for modifications to drug release profiles
Y Wang, DG Yu, Y Liu, YN Liu - Journal of Functional Biomaterials, 2022 - mdpi.com
Electrospinning is an advanced technology for the preparation of drug-carrying nanofibers
that has demonstrated great advantages in the biomedical field. Electrospun nanofiber …
that has demonstrated great advantages in the biomedical field. Electrospun nanofiber …
[HTML][HTML] Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers
Silica nanoparticles (SNP) have gained tremendous attention in the recent decades. They
have been used in many different biomedical fields including diagnosis, biosensing and …
have been used in many different biomedical fields including diagnosis, biosensing and …
[HTML][HTML] Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era
L Lin, J Chi, Y Yan, R Luo, X Feng, Y Zheng… - … Pharmaceutica Sinica B, 2021 - Elsevier
Membrane-disruptive peptides/peptidomimetics (MDPs) are antimicrobials or
anticarcinogens that present a general killing mechanism through the physical disruption of …
anticarcinogens that present a general killing mechanism through the physical disruption of …
[HTML][HTML] A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery
P Kolimi, S Narala, AAA Youssef, D Nyavanandi… - …, 2023 - ncbi.nlm.nih.gov
Recent advances in drug delivery technologies utilizing a variety of carriers have resulted in
a paradigm shift in the current approach to diagnosis and therapy. Mesoporous silica …
a paradigm shift in the current approach to diagnosis and therapy. Mesoporous silica …
Recent advances in drug delivery systems for glaucoma treatment
KD Patel, LB Silva, Y Park, T Shakouri… - Materials Today …, 2022 - Elsevier
Glaucoma is a chronic eye disease and the second most leading cause of irreversible
impaired vision in the world, which is primarily linked with high intraocular pressure (IOP) …
impaired vision in the world, which is primarily linked with high intraocular pressure (IOP) …
Inorganic nanoparticles in bone healing applications
Modern biomedicine aims to develop integrated solutions that use medical,
biotechnological, materials science, and engineering concepts to create functional …
biotechnological, materials science, and engineering concepts to create functional …
Functionalization of nanoparticulate drug delivery systems and its influence in cancer therapy
Research into the application of nanocarriers in the delivery of cancer-fighting drugs has
been a promising research area for decades. On the other hand, their cytotoxic effects on …
been a promising research area for decades. On the other hand, their cytotoxic effects on …
The effect of size, morphology and surface properties of mesoporous silica nanoparticles on pharmacokinetic aspects and potential toxicity concerns
U Niroumand, N Firouzabadi, G Goshtasbi… - Frontiers in …, 2023 - frontiersin.org
Mesoporous silica nanoparticles (MSNs) are considered as suitable delivery vehicles
considering their unique characteristics. Various physicochemical characteristics of MSNs …
considering their unique characteristics. Various physicochemical characteristics of MSNs …
Mesoporous silica nanoparticles and mesoporous bioactive glasses for wound management: from skin regeneration to cancer therapy
Exploring new therapies for managing skin wounds is under progress and, in this regard,
mesoporous silica nanoparticles (MSNs) and mesoporous bioactive glasses (MBGs) offer …
mesoporous silica nanoparticles (MSNs) and mesoporous bioactive glasses (MBGs) offer …
Carbon dot incorporated mesoporous silica nanoparticles for targeted cancer therapy and fluorescence imaging
A new and efficient theranostic nanoplatform was developed via a green approach for
targeted cancer therapy and fluorescence imaging, without the use of any anticancer …
targeted cancer therapy and fluorescence imaging, without the use of any anticancer …